Presentation is loading. Please wait.

Presentation is loading. Please wait.

Economic Impact of Palifermin on the Costs of Hospitalization for Autologous Hematopoietic Stem-Cell Transplant: Analysis of Phase 3 Trial Results  Linda.

Similar presentations


Presentation on theme: "Economic Impact of Palifermin on the Costs of Hospitalization for Autologous Hematopoietic Stem-Cell Transplant: Analysis of Phase 3 Trial Results  Linda."— Presentation transcript:

1 Economic Impact of Palifermin on the Costs of Hospitalization for Autologous Hematopoietic Stem-Cell Transplant: Analysis of Phase 3 Trial Results  Linda S. Elting, Ya-Chen Tina Shih, Patrick J. Stiff, William Bensinger, Scott B. Cantor, Catherine Cooksley, Ricardo Spielberger, Christos Emmanoulides  Biology of Blood and Marrow Transplantation  Volume 13, Issue 7, Pages (July 2007) DOI: /j.bbmt Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Relationship between duration of hospitalization and number of adverse outcomes. Adverse outcomes include febrile neutropenia, bacteremia, pneumonia, and total parenteral nutrition. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Cost estimates for the base-case scenario.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Economic Impact of Palifermin on the Costs of Hospitalization for Autologous Hematopoietic Stem-Cell Transplant: Analysis of Phase 3 Trial Results  Linda."

Similar presentations


Ads by Google